Articles: critical-care.
-
Critical care medicine · Jul 1997
Randomized Controlled Trial Multicenter Study Comparative Study Clinical TrialA comparison of cisatracurium (51W89) and atracurium by infusion in critically ill patients.
To evaluate and compare the safety and efficacy of cisatracurium (51W89) and atracurium administered by continuous infusion to critically ill patients requiring neuromuscular blocking agents to facilitate mechanical ventilation. ⋯ Cisatracurium, an isomer of atracurium, appears to be a suitable agent for providing muscle relaxation in critically ill patients.
-
A critical evaluation of monitoring in critical illness must recognize first that there are many different types of monitoring that may take place, and that each type of monitor may be evaluated appropriately by different standards. Monitoring may occur with imaging devices, analyzers that require the permanent removal of tissue or fluid for analysis, or monitors that observe physiology with either invasive or noninvasive methods without requiring an ex vivo sample.
-
Clinical Trial Controlled Clinical Trial
Development of a policy for patients receiving neuromuscular blocking agents.
To develop a policy to standardize the care of patients paralyzed with neuromuscular blocking agents (NMBAs). ⋯ The policy was useful as an educational tool. A NMBA order form should be developed to improve adherence to the policy.